InvestorsHub Logo
Replies to #39863 on Biotech Values
icon url

dewophile

12/26/06 8:12 AM

#39871 RE: rfj1862 #39863

great job on the rmf!
my only commments.under "competitors" i might add lupron as treatment option for fibroids..it has an fda label for 3 months to shrink/tx fibroids
I would also add birth control pills as treatment option for endometriosis
very minor points - thanks!
icon url

donotknowityet

12/26/06 11:04 AM

#39889 RE: rfj1862 #39863

John, RPRX's proellex competes with AEZS's Cetrorelix, that completed a seven Phase II program in endometriosis.

What is your take on it?

Pump: I am long in AEZS. It has a huge pipeline that comes pretty much free, as its approved medications, cash, its share of Atrium (ATB.TO itself a very undervalued nutritional company about to be distributed to shareholders) and royalty revenues from already approved drugs essentially cover the current share price.

Dunno